FIBROBLAST GROWTH FACTOR 21 POTENTLY REDUCES ATHEROSCLEROSIS AND NASH DEVELOPMENT

被引：0
|
作者：
Liu, C. [1 ,2 ]
Schonke, M. [1 ,2 ]
Spoorenberg, B. [1 ,2 ]
Lambooij, J. [3 ,4 ]
Hendrik, V. D. Z. [3 ]
Zhou, E. [1 ,2 ]
Dekker, N. [5 ]
Andreasson, A-C [6 ]
Park, A. [7 ]
Uhrbom, M. [6 ]
Ahlstedt, I. [6 ]
Ikeda, Y. [7 ]
Wallenius, K. [6 ]
Peng, X-R [6 ]
Guigas, B. [3 ]
Boon, M. [1 ,2 ]
Wang, Y. [1 ,2 ]
Rensen, P. [1 ,2 ]
机构：
[1] Leiden Univ, Dept Med, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands
[4] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands
[5] AstraZeneca BioPharmaceut R&D, Discovery Sci, Gothenburg, Sweden
[6] AstraZeneca, BioPharmaceut R&D, Biosci Metab Res & Early Dev Cardiovascr Renal &, Gothenburg, Sweden
[7] AstraZeneca, Oncol R&D, Biol Engn & Targeted Delivery, Gaithersburg, MD USA
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SE123
引用
收藏
页码：E74 / E75
页数：2
相关论文
共 50 条
  • [21] Fibroblast Growth Factor 21 in Patients with Acromegaly
    Halupczok-Zyla, Jowita
    Jawiarczyk-Przybylowska, Aleksandra
    Skrzypski, Marek
    Strowski, Mathias Z.
    Bolanowski, Marek
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (10) : 649 - 654
  • [22] Fibroblast growth factor 21 and bone homeostasis
    Tang, Yan
    Zhang, Mei
    BIOMEDICAL JOURNAL, 2023, 46 (04)
  • [23] Fibroblast growth factor 21 in heart failure
    Tucker, William
    Tucker, Bradley
    Rye, Kerry-Anne
    Ong, Kwok Leung
    HEART FAILURE REVIEWS, 2023, 28 (01) : 261 - 272
  • [24] Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
    Jin, Leigang
    Lin, Zhuofeng
    Xu, Aimin
    DIABETES & METABOLISM JOURNAL, 2016, 40 (01) : 22 - 31
  • [25] Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis
    Anuwatmatee, Sahapab
    Allison, Matthew A.
    Shlipak, Michael G.
    McClelland, Robyn L.
    Kramer, Holly
    Tang, Shudi
    Hou, Liming
    Rye, Kerry-Anne
    Ong, Kwok Leung
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (06) : 1009 - 1016
  • [26] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Yang Xiao
    Lingjiao Liu
    Aimin Xu
    Pengcheng Zhou
    Zhaofeng Long
    Yiting Tu
    Xiaoyan Chen
    Weili Tang
    Gan Huang
    Zhiguang Zhou
    Cardiovascular Diabetology, 14
  • [27] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Xiao, Yang
    Liu, Lingjiao
    Xu, Aimin
    Zhou, Pengcheng
    Long, Zhaofeng
    Tu, Yiting
    Chen, Xiaoyan
    Tang, Weili
    Huang, Gan
    Zhou, Zhiguang
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [28] Fibroblast growth factor 21 inhibits atherosclerosis in apoE−/− mice by ameliorating Fas-mediated apoptosis
    Xinxin Yan
    Zhongshan Gou
    Yuan Li
    Yu Wang
    Jingyan Zhu
    Guidong Xu
    Qian Zhang
    Lipids in Health and Disease, 17
  • [29] Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21
    Dunshee, Diana Ronai
    Bainbridge, Travis W.
    Kljavin, Noelyn M.
    Zavala-Solorio, Jose
    Schroeder, Amy C.
    Chan, Ruby
    Corpuz, Racquel
    Wong, Manda
    Zhou, Wei
    Deshmukh, Gauri
    Ly, Justin
    Sutherlin, Daniel P.
    Ernst, James A.
    Sonoda, Junichiro
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (11) : 5986 - 5996
  • [30] Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
    Tanaka, Naoki
    Takahashi, Shogo
    Zhang, Yuan
    Krausz, Kristopher W.
    Smith, Philip B.
    Patterson, Andrew D.
    Gonzalez, Frank J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (07): : 1242 - 1252
12345